New factor XIa inhibitors cut recurrent non-cardioembolic stroke without extra bleeding—plus what milvexian and abilacimab trials reveal. In this installment of this series, ‘The Future of Factor XIa ...
Israel's Prime Minister Benjamin Netanyahu is greeted by President Donald Trump as he arrives at the West Wing of the White House in Washington, Monday, April 7, 2025, in Washington. (AP Photo/Mark ...
A measure included in the House’s version of the fiscal 2027 defense bill calls for more integration between U.S. and Israeli defense technology sectors — an idea that is receiving pushback before the ...
NYC hardcore pioneers Cro-Mags are back with their first new song in six years, “Wired for Chaos,” which premieres today exclusively on Rolling Stone. As for the lyrics, the song finds Flanagan ...
Dan Raby, the senior digital producer for CBS News Atlanta, has been covering everything happening around Georgia for more than a decade. After months of campaigning, the 2026 primary elections in ...
The multi-agent clinical decision support system designed for metabolic, anabolic, and longevity medicine has onboarded 400 practitioners and 10 enterprise customers. Hormonaly.ai™, a clinical ...
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.
OpenAI announced GPT-5.5, its latest AI model that is better at coding, using computers and pursuing deeper research capabilities. The launch comes just weeks after Anthropic unveiled Claude Mythos ...
Google LLC has released two artificial intelligence agents that can generate research reports about user-specified topics. The agents made their debut on Tuesday. Deep Research and Deep Research Max ...
Agentic AI is the tech industry’s newest success story, and companies like OpenAI and Anthropic are racing to give enterprises the tools they need to create these automated little helpers. To that end ...
Plenary Presentation Highlights How Aligning Inflammatory Biomarker Enrichment with Mechanism of Action Offers a Blueprint for Success in Alzheimer’s Drug Development Dr. Tansey is among the most ...